Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer

X Liu, G Yan, B Xu, H Yu, Y An, M Sun - Frontiers in Immunology, 2022 - frontiersin.org
Background Macrophage infiltration is crucial for colorectal cancer (CRC) immunotherapy.
Detailed classification of macrophage subsets will facilitate the selection of patients suitable …

Indoleamine 2, 3-dioxygenase 1 and CD8 expression profiling revealed an immunological subtype of colon cancer with a poor prognosis

R Zhang, T Li, W Wang, W Gan, S Lv, Z Zeng… - Frontiers in …, 2020 - frontiersin.org
Background The Immunoscore method, based on the distribution of the quantification of
cytotoxic and memory T cells, provides an indicator of tumor recurrence for colon cancer …

CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer

SJ Lee, SY Jun, IH Lee, BW Kang, SY Park… - Journal of cancer …, 2018 - Springer
Purpose This study attempted to reveal the prognostic impact of microsatellite instability-high
(MSI-H) colon cancer with tumor-infiltrating immune cells (TIICs) and immune checkpoint …

Weighted gene co-expression network analysis identifies CALD1 as a biomarker related to M2 macrophages infiltration in stage III and IV mismatch repair-proficient …

H Zheng, Y Bai, J Wang, S Chen, J Zhang… - Frontiers in Molecular …, 2021 - frontiersin.org
Immunotherapy has achieved efficacy for advanced colorectal cancer (CRC) patients with a
mismatch-repair-deficient (dMMR) subtype. However, little immunotherapy efficacy was …

Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer

X Wu, J Li, Y Zhang, Y Cheng, Z Wu… - Gastroenterology …, 2023 - academic.oup.com
Background The tumor microenvironment plays an essential role in the therapeutic
response to immunotherapy. It is necessary to identify immune cell infiltration (ICI) subtypes …

The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy

YQ Tang, TF Chen, Y Zhang, XC Zhao… - Gastroenterology …, 2020 - academic.oup.com
Background Biomarkers based on immune context may guide prognosis prediction. T-cell
inactivation, exclusion, or dysfunction could cause unfavorable tumor microenvironments …

Immune-infiltrating signature-based classification reveals CD103+CD39+ T cells associate with colorectal cancer prognosis and response to immunotherapy

Y Luo, Y Zong, H Hua, M Gong, Q Peng, C Li… - Frontiers in …, 2022 - frontiersin.org
Background Current stratification systems for tumor prognostic prediction and
immunotherapeutic efficacy evaluation are less satisfying in colorectal cancer (CRC). As …

Global Pattern of CD8+ T-Cell Infiltration and Exhaustion in Colorectal Cancer Predicts Cancer Immunotherapy Response

S Tian, F Wang, R Zhang, G Chen - Frontiers in pharmacology, 2021 - frontiersin.org
Background: The MSI/MSS status does not fully explain cancer immunotherapy response in
colorectal cancer. Thus, we developed a colorectal cancer-specific method that predicts …

Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer

Y Sun, H Li, Z Ma, J Wang, H Yang, X Zhang, B Liu - Plos one, 2022 - journals.plos.org
Immune composition is commonly heterogeneous and varies among colorectal cancer
(CRC) patients. A comprehensive immune classification may act as important characteristics …

[HTML][HTML] The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal …

J Tang, L Ming, F Qin, Y Qin, D Wang, L Huang, Y Cao… - Immunobiology, 2024 - Elsevier
Abstract Tumor-associated macrophages (TAMs), one of the major immune cell types in
colorectal cancer (CRC) tumor microenvironment (TME), play indispensable roles in …